PeptideDB

AS1269574 330981-72-1

AS1269574 330981-72-1

CAS No.: 330981-72-1

AS1269574 is a potent, orally bioactive GPR119 agonist with EC50 of 2.5 μM in HEK293 cells expressing human GPR119. AS1
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

AS1269574 is a potent, orally bioactive GPR119 agonist with EC50 of 2.5 μM in HEK293 cells expressing human GPR119. AS1269574 activates the TRPA1 cation channel and stimulates glucagon-like peptide-1 (GLP-1) secretion. AS1269574 specifically induces glucose-dependent insulin secretion from pancreatic beta cells only under high glucose conditions. AS1269574 may be utilized in type 2 diabetes research.

Physicochemical Properties


Molecular Formula C13H14BRN3O
Molecular Weight 308.173761844635
Exact Mass 307.032
Elemental Analysis C, 50.67; H, 4.58; Br, 25.93; N, 13.64; O, 5.19
CAS # 330981-72-1
PubChem CID 5332859
Appearance Light yellow to yellow solid powder
Density 1.5±0.1 g/cm3
Boiling Point 386.9±42.0 °C at 760 mmHg
Flash Point 187.8±27.9 °C
Vapour Pressure 0.0±0.9 mmHg at 25°C
Index of Refraction 1.648
LogP 2.32
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 4
Rotatable Bond Count 4
Heavy Atom Count 18
Complexity 246
Defined Atom Stereocenter Count 0
SMILES

CC1=CC(=NCCO)N=C(C2=CC=C(C=C2)Br)N1

InChi Key DUKPGOOUJNUIOI-UHFFFAOYSA-N
InChi Code

InChI=1S/C13H14BrN3O/c1-9-8-12(15-6-7-18)17-13(16-9)10-2-4-11(14)5-3-10/h2-5,8,18H,6-7H2,1H3,(H,15,16,17)
Chemical Name

2-[[2-(4-bromophenyl)-6-methylpyrimidin-4-yl]amino]ethanol
Synonyms

AS1269574; AS-1269574; AS 1269574
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: This product requires protection from light (avoid light exposure) during transportation and storage.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vivo AS1269574 significantly lowered blood glucose AUC 2 hours after injection (AUC0-2h)[1].
Animal Protocol Animal/Disease Models: 8weeks old ICR mice [1]
Doses: 100 mg/kg
Route of Administration: Po
Experimental Results: Blood glucose AUC was Dramatically diminished after 2 hrs (hrs (hours)) of administration (AUC0-2h). Similarly, mouse plasma insulin AUC0-2h was Dramatically higher.
References

[1]. Identification of a novel GPR119 agonist, AS1269574, with in vitro and in vivo glucose-stimulated insulin secretion. Biochem Biophys Res Commun. 2010;400(3):437-441.

[2]. GPR119 Agonist AS1269574 Activates TRPA1 Cation Channels to Stimulate GLP-1 Secretion. Mol Endocrinol. 2016;30(6):614-629.

Additional Infomation AS-1269574 is an organobromine compound.

Solubility Data


Solubility (In Vitro) DMSO : ~250 mg/mL (~811.24 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.08 mg/mL (6.75 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.08 mg/mL (6.75 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.08 mg/mL (6.75 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 3.2450 mL 16.2248 mL 32.4496 mL
5 mM 0.6490 mL 3.2450 mL 6.4899 mL
10 mM 0.3245 mL 1.6225 mL 3.2450 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.